Your browser doesn't support javascript.
loading
Emerging Roles for Serotonin in Regulating Metabolism: New Implications for an Ancient Molecule.
Yabut, Julian M; Crane, Justin D; Green, Alexander E; Keating, Damien J; Khan, Waliul I; Steinberg, Gregory R.
Afiliação
  • Yabut JM; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Crane JD; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
  • Green AE; Department of Biology, Northeastern University, Boston, Massachusetts.
  • Keating DJ; Division of Endocrinology and Metabolism, Department of Medicine, McMaster University, Hamilton, Ontario, Canada.
  • Khan WI; Centre for Metabolism, Obesity and Diabetes Research, McMaster University, Hamilton, Ontario, Canada.
  • Steinberg GR; College of Medicine and Public Health, Flinders University, Bedford Park, South Australia, Australia.
Endocr Rev ; 40(4): 1092-1107, 2019 08 01.
Article em En | MEDLINE | ID: mdl-30901029
ABSTRACT
Serotonin is a phylogenetically ancient biogenic amine that has played an integral role in maintaining energy homeostasis for billions of years. In mammals, serotonin produced within the central nervous system regulates behavior, suppresses appetite, and promotes energy expenditure by increasing sympathetic drive to brown adipose tissue. In addition to these central circuits, emerging evidence also suggests an important role for peripheral serotonin as a factor that enhances nutrient absorption and storage. Specifically, glucose and fatty acids stimulate the release of serotonin from the duodenum, promoting gut peristalsis and nutrient absorption. Serotonin also enters the bloodstream and interacts with multiple organs, priming the body for energy storage by promoting insulin secretion and de novo lipogenesis in the liver and white adipose tissue, while reducing lipolysis and the metabolic activity of brown and beige adipose tissue. Collectively, peripheral serotonin acts as an endocrine factor to promote the efficient storage of energy by upregulating lipid anabolism. Pharmacological inhibition of serotonin synthesis or signaling in key metabolic tissues are potential drug targets for obesity, type 2 diabetes, and nonalcoholic fatty liver disease (NAFLD).
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Serotonina Limite: Animals / Humans Idioma: En Revista: Endocr Rev Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Serotonina Limite: Animals / Humans Idioma: En Revista: Endocr Rev Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá País de publicação: EEUU / ESTADOS UNIDOS / ESTADOS UNIDOS DA AMERICA / EUA / UNITED STATES / UNITED STATES OF AMERICA / US / USA